PHD.L Regulatory News (PHD)

PROACTIS Holdings PLC

("PROACTIS" or "the Company")

Grant of options

The Company announces that on 25 January 2012 300,000 options over the Company's ordinary shares of 10 pence each ("Ordinary Shares") were granted to certain directors pursuant to the PROACTIS Holdings PLC Enterprise Management Incentive Scheme ("the EMI scheme"). In addition, 50,000 options over the Company's Ordinary Shares were granted to a director pursuant to the PROACTIS Holdings PLC Executive Share Option Scheme ("the ESO scheme") (together, "the Options"). The Options were granted for nil consideration with an exercise price of 24 pence per share and vest and are exercisable over a three year period from the date of grant subject to the share price of the Company performing beyond that of the AIM Technology Index.

Following the grant, the interests of directors in Options are as follows:

Name Scheme Options granted Total options

Rod Jones EMI scheme 50,000 275,000

Sean McDonough EMI scheme 200,000 500,000

Kevin Chidlow EMI scheme 50,000 265,000

Tim Sykes ESO scheme 50,000 676,842

Save for the above the directors' beneficial interests remain unchanged and as previously announced.

- ends -

Enquiries:

PROACTIS 019 3754 5070

Rod Jones, Chief Executive Officer

Tim Sykes, Chief Financial Officer

finnCap Limited 020 7600 1658

Marc Young / Charlotte Stranner

PROACTIS creates, sells and maintains specialist software which enables organisations to streamline, control and monitor all internal and external expenditure, other than payroll. PROACTIS is used in over 300 organisations in the UK from the commercial, public and not-for-profit sectors.